153 related articles for article (PubMed ID: 15837131)
21. Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes.
Hobson GM; Huang Z; Sperle K; Sistermans E; Rogan PK; Garbern JY; Kolodny E; Naidu S; Cambi F
Hum Mutat; 2006 Jan; 27(1):69-77. PubMed ID: 16287154
[TBL] [Abstract][Full Text] [Related]
22. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
23. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.
Vaurs-Barrière C; Deville M; Sarret C; Giraud G; Des Portes V; Prats-Viñas JM; De Michele G; Dan B; Brady AF; Boespflug-Tanguy O; Touraine R
Ann Neurol; 2009 Jan; 65(1):114-8. PubMed ID: 19194886
[TBL] [Abstract][Full Text] [Related]
24. Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect.
Lee JA; Madrid RE; Sperle K; Ritterson CM; Hobson GM; Garbern J; Lupski JR; Inoue K
Ann Neurol; 2006 Feb; 59(2):398-403. PubMed ID: 16374829
[TBL] [Abstract][Full Text] [Related]
25. Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication.
Shimojima K; Inoue T; Imai Y; Arai Y; Komoike Y; Sugawara M; Fujita T; Ideguchi H; Yasumoto S; Kanno H; Hirose S; Yamamoto T
J Hum Genet; 2012 Sep; 57(9):580-6. PubMed ID: 22695888
[TBL] [Abstract][Full Text] [Related]
26. A PLP splicing abnormality is associated with an unusual presentation of PMD.
Hobson GM; Huang Z; Sperle K; Stabley DL; Marks HG; Cambi F
Ann Neurol; 2002 Oct; 52(4):477-88. PubMed ID: 12325077
[TBL] [Abstract][Full Text] [Related]
27. Rabbit paralytic tremor phenotype--a plp1 gene mutation as a model of human Pelizaeus-Merzbacher disease.
Sypecka J; Domańska-Janik K
Acta Neurobiol Exp (Wars); 2005; 65(2):221-9. PubMed ID: 15960310
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease.
Carango P; Funanage VL; Quirós RE; Debruyn CS; Marks HG
Ann Neurol; 1995 Oct; 38(4):610-7. PubMed ID: 7574457
[TBL] [Abstract][Full Text] [Related]
29. [Duplication of the PLP gene and the classical form of Pelizaeus-Merzbacher disease].
Blanco-Barca MO; Eirís-Puñal J; Soler-Regal C; Castro-Gago M
Rev Neurol; 2003 Sep 1-15; 37(5):436-8. PubMed ID: 14533091
[TBL] [Abstract][Full Text] [Related]
30. Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease.
Hübner CA; Orth U; Senning A; Steglich C; Kohlschütter A; Korinthenberg R; Gal A
Hum Mutat; 2005 Mar; 25(3):321-2. PubMed ID: 15712223
[TBL] [Abstract][Full Text] [Related]
31. Girl with signs of Pelizaeus-Merzbacher disease heterozygous for a mutation in exon 2 of the proteolipid protein gene.
Hodes ME; DeMyer WE; Pratt VM; Edwards MK; Dlouhy SR
Am J Med Genet; 1995 Feb; 55(4):397-401. PubMed ID: 7539211
[TBL] [Abstract][Full Text] [Related]
32. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders.
Lee JA; Carvalho CM; Lupski JR
Cell; 2007 Dec; 131(7):1235-47. PubMed ID: 18160035
[TBL] [Abstract][Full Text] [Related]
33. Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease.
Lee JA; Inoue K; Cheung SW; Shaw CA; Stankiewicz P; Lupski JR
Hum Mol Genet; 2006 Jul; 15(14):2250-65. PubMed ID: 16774974
[TBL] [Abstract][Full Text] [Related]
34. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
[TBL] [Abstract][Full Text] [Related]
35. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
36. [Early diagnosis of a serious form of Pelizaeus-Merzbacher's disease confirmed by molecular analysis of the gene for proto-lipoproteins].
López-Pisón J; Muñoz-Albillos M; Moros-Peña M; Medrano-Marina P; Ruiz-Escusol S; Boespflug-Tanguy O
Rev Neurol; 1999 Sep 1-15; 29(5):429-32. PubMed ID: 10584245
[TBL] [Abstract][Full Text] [Related]
37. Clinical and genetic characterization of a 2-year-old boy with complete PLP1 deletion.
Torisu H; Iwaki A; Takeshita K; Hiwatashi A; Sanefuji M; Fukumaki Y; Hara T
Brain Dev; 2012 Nov; 34(10):852-6. PubMed ID: 22401669
[TBL] [Abstract][Full Text] [Related]
38. Further genotype-phenotype correlation emerging from two families with PLP1 exon 4 skipping.
Biancheri R; Grossi S; Regis S; Rossi A; Corsolini F; Rossi DP; Cavalli P; Severino M; Filocamo M
Clin Genet; 2014 Mar; 85(3):267-72. PubMed ID: 23711321
[TBL] [Abstract][Full Text] [Related]
39. Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease.
Henneke M; Gegner S; Hahn A; Plecko-Startinig B; Weschke B; Gärtner J; Brockmann K
Neurology; 2010 Jun; 74(22):1785-9. PubMed ID: 20513814
[TBL] [Abstract][Full Text] [Related]
40. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
Hobson GM; Garbern JY
Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
